EMEA (Europe, Middle East and Africa) Neurotherapeutic Drugs Market Report 2017

December 2017 | 102 pages | ID: EBC9B40D8AFEN
QYResearch

Abstracts

In this report, the EMEA Neurotherapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Neurotherapeutic Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Neurotherapeutic Drugs market competition by top manufacturers/players, with Neurotherapeutic Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abbott
• BD
• Novartis AG
• Johnson & Johnson
• Pfizer
• Sanofi-Aventis
• Biogen
• GlaxoSmithKline
• AstraZeneca
• Merck

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Peripheral Nervous System Disorders (PNS) Disorder
• Autonomous Nervous System (ANS) Disorder
• Central Nervous System (CNS) Disorders
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hosptical
• Drug Stores
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Neurotherapeutic Drugs Market Report 2017

1 NEUROTHERAPEUTIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Neurotherapeutic Drugs
1.2 Classification of Neurotherapeutic Drugs
  1.2.1 EMEA Neurotherapeutic Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Neurotherapeutic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Peripheral Nervous System Disorders (PNS) Disorder
  1.2.4 Autonomous Nervous System (ANS) Disorder
  1.2.5 Central Nervous System (CNS) Disorders
  1.2.6 Other
1.3 EMEA Neurotherapeutic Drugs Market by Application/End Users
  1.3.1 EMEA Neurotherapeutic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hosptical
  1.3.3 Drug Stores
  1.3.4 Other
1.4 EMEA Neurotherapeutic Drugs Market by Region
  1.4.1 EMEA Neurotherapeutic Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Neurotherapeutic Drugs (2012-2022)
  1.5.1 EMEA Neurotherapeutic Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Neurotherapeutic Drugs Revenue and Growth Rate (2012-2022)

2 EMEA NEUROTHERAPEUTIC DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Neurotherapeutic Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Neurotherapeutic Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Neurotherapeutic Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Neurotherapeutic Drugs Sale Price by Players (2012-2017)
2.2 EMEA Neurotherapeutic Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Neurotherapeutic Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Neurotherapeutic Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Neurotherapeutic Drugs Sale Price by Type (2012-2017)
2.3 EMEA Neurotherapeutic Drugs (Volume) by Application
2.4 EMEA Neurotherapeutic Drugs (Volume and Value) by Region
  2.4.1 EMEA Neurotherapeutic Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Neurotherapeutic Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Neurotherapeutic Drugs Sales Price by Region (2012-2017)

3 EUROPE NEUROTHERAPEUTIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Neurotherapeutic Drugs Sales and Value (2012-2017)
  3.1.1 Europe Neurotherapeutic Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Neurotherapeutic Drugs Sales and Market Share by Type
3.3 Europe Neurotherapeutic Drugs Sales and Market Share by Application
3.4 Europe Neurotherapeutic Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Neurotherapeutic Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Neurotherapeutic Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NEUROTHERAPEUTIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Neurotherapeutic Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Neurotherapeutic Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Neurotherapeutic Drugs Sales and Market Share by Type
4.3 Middle East Neurotherapeutic Drugs Sales and Market Share by Application
4.4 Middle East Neurotherapeutic Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Neurotherapeutic Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Neurotherapeutic Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)

5 AFRICA NEUROTHERAPEUTIC DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Neurotherapeutic Drugs Sales and Value (2012-2017)
  5.1.1 Africa Neurotherapeutic Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Neurotherapeutic Drugs Sales and Market Share by Type
5.3 Africa Neurotherapeutic Drugs Sales and Market Share by Application
5.4 Africa Neurotherapeutic Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Neurotherapeutic Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Neurotherapeutic Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Neurotherapeutic Drugs Sales and Growth Rate (2012-2017)

6 EMEA NEUROTHERAPEUTIC DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abbott
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 BD
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 BD Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis AG Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sanofi-Aventis
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biogen
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biogen Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 AstraZeneca
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 AstraZeneca Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merck
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Neurotherapeutic Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck Neurotherapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 NEUROTHERAPEUTIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Neurotherapeutic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neurotherapeutic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neurotherapeutic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NEUROTHERAPEUTIC DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Neurotherapeutic Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Neurotherapeutic Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Neurotherapeutic Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Neurotherapeutic Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Neurotherapeutic Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neurotherapeutic Drugs
Figure EMEA Neurotherapeutic Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Neurotherapeutic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Peripheral Nervous System Disorders (PNS) Disorder Product Picture
Figure Autonomous Nervous System (ANS) Disorder Product Picture
Figure Central Nervous System (CNS) Disorders Product Picture
Figure Other Product Picture
Figure EMEA Neurotherapeutic Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Neurotherapeutic Drugs by Application in 2016
Figure Hosptical Examples
Table Key Downstream Customer in Hosptical
Figure Drug Stores Examples
Table Key Downstream Customer in Drug Stores
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Neurotherapeutic Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Neurotherapeutic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Neurotherapeutic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Neurotherapeutic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Neurotherapeutic Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Neurotherapeutic Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Neurotherapeutic Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Neurotherapeutic Drugs Sales Share by Players (2012-2017)
Figure 2016 Neurotherapeutic Drugs Sales Share by Players
Figure 2017 Neurotherapeutic Drugs Sales Share by Players
Figure EMEA Neurotherapeutic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Neurotherapeutic Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Neurotherapeutic Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Neurotherapeutic Drugs Revenue Share by Players
Table 2017 EMEA Neurotherapeutic Drugs Revenue Share by Players
Table EMEA Neurotherapeutic Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Neurotherapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Neurotherapeutic Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Neurotherapeutic Drugs by Type (2012-2017)
Figure EMEA Neurotherapeutic Drugs Sales Market Share by Type (2012-2017)
Table EMEA Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Neurotherapeutic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neurotherapeutic Drugs by Type in 2016
Table EMEA Neurotherapeutic Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Neurotherapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Neurotherapeutic Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Neurotherapeutic Drugs by Application (2012-2017)
Figure EMEA Neurotherapeutic Drugs Sales Market Share by Application in 2016
Table EMEA Neurotherapeutic Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Neurotherapeutic Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Neurotherapeutic Drugs by Region (2012-2017)
Figure EMEA Neurotherapeutic Drugs Sales Market Share in 2016
Table EMEA Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Neurotherapeutic Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Neurotherapeutic Drugs by Region (2012-2017)
Figure EMEA Neurotherapeutic Drugs Revenue Market Share Regions in 2016
Table EMEA Neurotherapeutic Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017)
Table Europe Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017)
Table Europe Neurotherapeutic Drugs Market Share by Type (2012-2017)
Figure Europe Neurotherapeutic Drugs Market Share by Type in 2016
Table Europe Neurotherapeutic Drugs Sales (K Units) by Application (2012-2017)
Table Europe Neurotherapeutic Drugs Market Share by Application (2012-2017)
Figure Europe Neurotherapeutic Drugs Market Share by Application in 2016
Table Europe Neurotherapeutic Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Neurotherapeutic Drugs Sales Market Share by Countries in 2016
Table Europe Neurotherapeutic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Neurotherapeutic Drugs Revenue Market Share by Countries in 2016
Figure Germany Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Neurotherapeutic Drugs Market Share by Type (2012-2017)
Figure Middle East Neurotherapeutic Drugs Market Share by Type (2012-2017)
Table Middle East Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Neurotherapeutic Drugs Market Share by Applications (2012-2017)
Figure Middle East Neurotherapeutic Drugs Sales Market Share by Application in 2016
Table Middle East Neurotherapeutic Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Neurotherapeutic Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Neurotherapeutic Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Neurotherapeutic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Neurotherapeutic Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017)
Table Africa Neurotherapeutic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Neurotherapeutic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Neurotherapeutic Drugs Sales Market Share by Type in 2016
Table Africa Neurotherapeutic Drugs Sales (K Units) by Application (2012-2017)
Table Africa Neurotherapeutic Drugs Sales Market Share by Application (2012-2017)
Figure Africa Neurotherapeutic Drugs Sales Market Share by Application (2012-2017)
Table Africa Neurotherapeutic Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Neurotherapeutic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Neurotherapeutic Drugs Sales Market Share by Countries in 2016
Table Africa Neurotherapeutic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Neurotherapeutic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Neurotherapeutic Drugs Revenue Market Share by Countries in 2016
Figure South Africa Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Abbott Neurotherapeutic Drugs Basic Information List
Table Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table BD Neurotherapeutic Drugs Basic Information List
Table BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BD Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure BD Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure BD Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Neurotherapeutic Drugs Basic Information List
Table Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis AG Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Neurotherapeutic Drugs Basic Information List
Table Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Neurotherapeutic Drugs Basic Information List
Table Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Neurotherapeutic Drugs Basic Information List
Table Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Biogen Neurotherapeutic Drugs Basic Information List
Table Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Biogen Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Biogen Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Neurotherapeutic Drugs Basic Information List
Table GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Neurotherapeutic Drugs Basic Information List
Table AstraZeneca Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck Neurotherapeutic Drugs Basic Information List
Table Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Neurotherapeutic Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck Neurotherapeutic Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurotherapeutic Drugs
Figure Manufacturing Process Analysis of Neurotherapeutic Drugs
Figure Neurotherapeutic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2016
Table Major Buyers of Neurotherapeutic Drugs
Table Distributors/Traders List
Figure EMEA Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Neurotherapeutic Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Neurotherapeutic Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Neurotherapeutic Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Neurotherapeutic Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Neurotherapeutic Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Neurotherapeutic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Neurotherapeutic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Neurotherapeutic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Neurotherapeutic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Neurotherapeutic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Neurotherapeutic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Neurotherapeutic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Neurotherapeutic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Neurotherapeutic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Neurotherapeutic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Neurotherapeutic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Neurotherapeutic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Neurotherapeutic Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Neurotherapeutic Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Neurotherapeutic Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Neurotherapeutic Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources